Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Single-center Randomized Study "Comparison of Safety and Effectiveness of the First Line of Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions in Primary Gastric Cancer With Isolated Peritoneal Carcinomatosis.

NCT06313801 is registered in ClinicalTrials.gov with Nizhny Novgorod Regional Clinical Oncology Center as lead sponsor.

NCT NCT06313801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06313801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Single-center Randomized Study "Comparison of Safety and Effectiveness of the First Line of Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions in Primary Gastric Cancer With Isolated Peritoneal Carcinomatosis.
Lead sponsor
Nizhny Novgorod Regional Clinical Oncology Center
Phase
Phase 2
Overall status
Recruiting
Start date
January 19, 2023
Completion date
September 1, 2027
Enrollment
106 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer